Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ONCORAL PHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 35481214
Amaliegade 6, 1256
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
0 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ONCORAL PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
MO
Magnus Olafsson Corfitzen
Chief Executive Officer
Chief Executive Officer
2017
Former (1)
PG
Peter Gudmund Nielsen
Management
Management
2013 – 2017
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Former (3)
MM
Mette Munch
Chairman
Chairman
2015 – 2017
JF
Jørn Frederik Falch
Chairman
Chairman
2013 – 2015
AV
Ann Vivian Fullerton
Board of Directors
Board of Directors
2013 – 2017
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Ascelia Pharma AB
Individual
100%
100%
2017
Styrelsen for Forskning og Uddannelse
Company
20–24.99%
20–24.99%
2016
PEBEAN HOLDING ApS
Company
66.67–89.99%
66.67–89.99%
2013
Uddannelses- og Forskningsstyrelsen
Company
20–24.99%
20–24.99%
2017
CAPNOVA A/S
Company
5–9.99%
5–9.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ONCORAL PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
